Conventional magnetic resonance imaging (MRI) measures of multiple sclerosis patients provide limited information about the nature and the extent of brain damage and repair. We established a clinically compatible protocol including quantitative MRI techniques (qMRI, T1, T2, T2* relaxometry) and semiquantitative Magnetisation Transfer Imaging to provide a comprehensive MRI fingerprint (CMF) of lesions that is more adherent to the real underlying pathology and to assess the CMF contribution to clinical performances in patients. Lesions characteristics, revealed by combination of q/sq MRI, highly correlated with patients clinical performance and more severe lesions appeared to drive the clinic-radiological correlations.
Tobias Kober, Tom Hilbert, Gian Franco Piredda
David Lyndon Emsley, Michael Allan Hope, Máté Visegrádi, Federico De Biasi
Jean-Philippe Thiran, Muhamed Barakovic, Erick Jorge Canales Rodriguez, Marco Pizzolato, Tim Bjørn Dyrby